Skip to main content

Pfizer, BioNTech request expanded emergency use of Covid-19 vaccine for ages 12-15

Pfizer and its German partner BioNtech on Friday said they have requested U.S. regulatory agencies to expand the emergency use of their Covid-19 vaccine in adolescents aged 12 to 15.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.